Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Middle East Respiratory Syndrome Coronavirus (MERS-CoV)”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Early research (Phase 1)Study completedNCT03615911
What this trial is testing

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

Who this might be right for
MERS (Middle East Respiratory Syndrome)
Marylyn Addo 26
Not applicableStudy completedNCT01056354
What this trial is testing

Respiratory Virus Outpatient Study (FLU 002 Plus)

Who this might be right for
Influenza and Other Novel Respiratory Viruses
University of Minnesota 11,719
Early research (Phase 1)Study completedNCT04170829
What this trial is testing

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Who this might be right for
Middle East Respiratory Syndrome Coronavirus
King Abdullah International Medical Research Center 24
Not applicableStudy completedNCT02497885
What this trial is testing

Seroprevalence of MERS-CoV IgG in Healthcare Workers

Who this might be right for
Coronavirus Infections
Ewha Womans University Mokdong Hospital 737
Not applicableStudy completedNCT02605109
What this trial is testing

Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)

Who this might be right for
Viral Infection
Konkuk University Medical Center 200
Early research (Phase 1)Ended earlyNCT03399578
What this trial is testing

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

Who this might be right for
MERS (Middle East Respiratory Syndrome)
University of Oxford 29
Early research (Phase 1)Study completedNCT02670187
What this trial is testing

Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers

Who this might be right for
Healthy
GeneOne Life Science, Inc. 75
Testing effectiveness (Phase 2)UnknownNCT04130594
What this trial is testing

Study of Safety and Immunogenicity of BVRS-GamVac

Who this might be right for
MERS (Middle East Respiratory Syndrome)MERS
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 162
Testing effectiveness (Phase 2)UnknownNCT04412395
What this trial is testing

Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease

Who this might be right for
Corona Virus InfectionMiddle East Respiratory Syndrome (MERS)Acute Respiratory Distress Syndrome+3 more
National Research Centre, Egypt 516
Early research (Phase 1)Study completedNCT03301090
What this trial is testing

A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051

Who this might be right for
Corona Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT06857318
What this trial is testing

Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.

Who this might be right for
COVID 19
Hadassah Medical Organization 43
Early research (Phase 1)Study completedNCT02627378
What this trial is testing

Saudi Outcomes of ECMO-treated MERS-CoV Patients

Who this might be right for
MERS-CoV InfectionRefractory Hypoxemia
Imam Abdulrahman Bin Faisal University 35
Testing effectiveness (Phase 2)Study completedNCT03721718
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers

Who this might be right for
Healthy
GeneOne Life Science, Inc. 60
Large-scale testing (Phase 3)Study completedNCT02845843
What this trial is testing

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b

Who this might be right for
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
King Abdullah International Medical Research Center 95
Not applicableStudy completedNCT01056185
What this trial is testing

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Who this might be right for
InfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
University of Minnesota 1,000
Testing effectiveness (Phase 2)WithdrawnNCT02190799
What this trial is testing

Anti-MERS-CoV Convalescent Plasma Therapy

Who this might be right for
Respiratory Distress Syndrome (& [Hyaline Membrane Disease])
King Abdullah International Medical Research Center
Early research (Phase 1)Study completedNCT04119440
What this trial is testing

Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS

Who this might be right for
MERS (Middle East Respiratory Syndrome)
Universitätsklinikum Hamburg-Eppendorf 145
Testing effectiveness (Phase 2)Study completedNCT04588428
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

Who this might be right for
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Inovio Pharmaceuticals 192
Early research (Phase 1)UnknownNCT05548439
What this trial is testing

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Who this might be right for
COVID-19Coronavirus Infections
VBI Vaccines Inc. 103
Testing effectiveness (Phase 2)UnknownNCT04128059
What this trial is testing

Study of Safety and Immunogenicity of BVRS-GamVac-Combi

Who this might be right for
MERS (Middle East Respiratory Syndrome)MERS
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 268
Load More Results